• 1
    National Cancer Institute (NCI). NCI website, lung cancer homepage. Available at: Accessed March 14, 2009.
  • 2
    Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the Surveillance, Epidemiologic, and End Results database. J Clin Oncol. 2006; 24: 4539-4544.
  • 3
    Iannuzzi MC, Scoggin CH. Small cell lung cancer. Am Rev Respir Dis. 1986; 134: 593-608.
  • 4
    Ichinose Y, Hara N, Otha M, et al. Comparison between resected and irradiated small cell lung cancer in patients in stages I through IIIA. Ann Thorac Cardiovasc Surg. 1992; 97: 168-176.
  • 5
    Elliott JA Osterling K, Hirsch FR, et al. Metastatic patterns in small cell lung cancer: correlation of autopsy findings with clinical parameters. J Clin Oncol. 1987; 5: 246-254.
  • 6
    Fox W, Scadding JG. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. Lancet. 1973; 2: 63-65.
  • 7
    Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1999; 341: 476-484.
  • 8
    Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol. 1992; 10: 890-895.
  • 9
    Prasad US, Naylor AR, Walker WS, et al. Long term survival after pulmonary resection for small cell carcinoma of the lung. Thorax. 1989; 44: 784-787.
  • 10
    Shields TW, Higgins GA Jr, Matthews MJ, et al. Surgical resection in the management of small cell carcinoma of the lung. J Thorac Cardiovasc Surg. 1982; 84: 481-488.
  • 11
    Shepherd FA, Ginsberg RJ, Patterson GA. A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study. J Thorac Cardiovasc Surg. 1989; 97: 177-1786.
  • 12
    Lewinski T, Zulawski M, Turski C, et al. Small cell lung cancer I-IIIA: cytorreductive chemotherapy followed by resection with continuation of chemotherapy. Eur J Cardiothorac Surg. 2001; 20: 391-398.
  • 13
    Inoue M, Miyoshi S, Yasumitsu T, et al. Surgical results for small cell lung cancer based on the new TNM staging system. Ann Thorac Surg. 2000; 70: 1615-1619.
  • 14
    Rea F, Callegaro D, Favaretto A, et al. Long term results of surgery and chemotherapy in small cell lung cancer. Eur J Cardiothorac Surg. 1998; 4: 398-402.
  • 15
    Eberhardt W, Stamatis G, Stuschke M, et al. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial. Br J Cancer. 1999; 81: 1206-1212.
  • 16
    Brock MV, Hooker CM, Syphard JE, et al. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: its time has come. J Thorac Cardiovasc Surg. 2005; 129: 64-70.
  • 17
    Tsuchiya R, Suzuki K, Ichinose Y, et al. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIA small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group (JCOG9101). J Thorac Cardiovasc Surg. 2005; 129: 977-983.
  • 18
    Shepherd FA, Evans WK, Feld V, et al. Adjuvant chemotherapy following surgical resection for small-cell carcinoma of the lung. J Clin Oncol. 1988; 6: 832-838.
  • 19
    Lin D, Wei LJ, Ying Z. Checking the Cox model with cumulative sums of Martingale-based residuals. Biometrika. 1993; 80: 557-572.
  • 20
    GreeneFL, PageDL, FlemingID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
  • 21
    National Comprehensive Cancer Network (NCCN). NCCN Practice Guidelines in Oncology, version 2.2009. Available at: Accessed March 14, 2009.
  • 22
    Lad T, Piantadosi S, Thomas P. A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy. Chest. 1994; 106: 320-323.
  • 23
    PORT Meta-Analysis Trialists Group. Postoperative radiotherapy for nonsmall cell lung carcinoma. Cochrane Database Syst Rev. 2005;( 18): CD002142.
  • 24
    Lally BE, Zelterman D, Colasanto JM, et al. Postoperative radiotherapy for stage II or III non small-cell lung cancer using the Surveillance, Epidemiology, and End Results database. J Clin Oncol. 2006; 24: 2998-3006.
  • 25
    Badzio A, Kurowski K, Karnicka-Mlodkowska H, et al. A retrospective comparative study of surgery followed by chemotherapy vs nonsurgical management in limited-disease small cell lung cancer. Eur J Cardiothorac Surg. 2004; 26: 183-188.
  • 26
    Douillard JY, Rosell R, De Lena M, et al. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA nonsmall-cell lung cancer treated with adjuvant chemotherapy: the Adjuvant Navelbine International Trialist Association (ANITA) randomized trial. Int J Radiat Oncol Biol Phys. 2008; 72: 695-701.
  • 27
    Eberhardt W, Korfee S. New approaches for small-cell lung cancer: local treatments. Cancer Control. 2003; 10: 289-296.